Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / DNLI - Denali: A $10B Early Stage Biotech Targeting Parkinson's Disease

DNLI - Denali: A $10B Early Stage Biotech Targeting Parkinson's Disease

Denali Therapeutics Inc.
  • Denali has a market cap of $10bn after Biogen's $1bn deal with it.
  • Its assets are in the early stages.
  • While 3 major biopharma companies have gambled on Denali, the stakes are too high right now.

For further details see:

Denali: A $10B Early Stage Biotech Targeting Parkinson's Disease
Stock Information
Company Name: Denali Therapeutics Inc.
Stock Symbol: DNLI
Market: NASDAQ
Website: denalitherapeutics.com
Menu
DNLI DNLI Quote DNLI Short DNLI News DNLI Articles DNLI Message Board
Get DNLI Alerts

News, Short Squeeze, Breakout and More Instantly...